UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	March 27, 2023

Accession Number:	0001628280-23-008604
Submission Type:	POS AM
CIK: 0001821586 Company Name: MoonLake Immunotherapeutics File Number: 333-262643